A forum on open access to peer–reviewed research articles and the dissemination of published research will be held from 3–5 p.m. on Thursday, February 10 in Harkness Auditorium of the Yale School of Medicine at 333 Cedar Street. The purpose of the forum...
Prions, infectious proteins associated with bovine spongiform encephalopathy (BSE) or Mad Cow Disease, were previously thought to accumulate mainly in the brain, but Yale and University of Zurich researchers report in Science that other organs can also...
Bayer Pharmaceuticals Corporation has named Raymond R. Russell, M.D., assistant professor of internal medicine in the section of cardiology at Yale School of Medicine, the Bayer Fellow in Medicine and Management for 2004–05. In 2002, Bayer made a...
Researchers at Yale School of Medicine and over 60 collaborating research sites received a $33 million grant from the National Institutes of Neurological Disorders and Stroke (NINDS) to conduct a multi-center trial examining a novel approach for treating...
Research by Yale professor of Chemistry, Mark A. Johnson on the structure and chemical behavior of water was highlighted as one of the ten most important of discoveries in 2004 by the preeminent journal Science. While water is considered the fluid of...
Nicholas M. Greene, M.D., who has been described as one of the founding fathers of modern anesthesiology around the country and at Yale, died December 28 at age 82 in New Haven. Founder of the Department of Anesthesiology at Yale School of Medicine,...
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response...
A combination of four proteins that result from inflammation and infection and lead to premature birth can be rapidly and accurately detected in the amniotic fluid of pregnant women using proteomics technology, Yale researchers report in two studies in...
Researchers at Yale School of Medicine and over 60 collaborating research sites received a $33 million grant from the National Institutes of Neurological Disorders and Stroke (NINDS) to conduct a multi-center trial examining a novel approach for treating...
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology called the ChemoFX assay, which could double the response...